Long-term outcome of pediatric renal transplantation: A single center study in Japan

Pediatric Transplantation

Volumn 18, Issue 5, 2014, Pages 453-462

  Yamada, Akio ^a   Tashiro, Atsushi ^a   Hiraiwa, Tomoko ^a   Komatsu, Tomonori ^a   Kinukawa, Tsuneo ^a   Ueda, Norishi ^b  

^a CHUKYO HOSPITAL   (Japan)

^b Public Central Hospital of Matto Ishikawa   (Japan)

Author keywords

cardiovascular events; gender; hypertension; immunosuppression; malignancy; rejection

Indexed keywords

ACUTE GRAFT REJECTION; ACUTE KIDNEY TUBULE NECROSIS; APLASTIC ANEMIA; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHILD; CHRONIC ALLOGRAFT INJURY; COLD ISCHEMIA; COLORECTAL CANCER; CRYPTOCOCCOSIS; CYTOMEGALOVIRUS INFECTION; ENTEROCOCCAL INFECTION; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULOPATHY; GRAFT FAILURE; GRAFT SURVIVAL; HEMOPHAGOCYTIC SYNDROME; HEPATOBLASTOMA; HUMAN; HYPERKALEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; JAPAN; JAPANESE (PEOPLE); KIDNEY DYSPLASIA; KIDNEY HYPOPLASIA; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVING DONOR; LONG TERM CARE; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; POSTOPERATIVE INFECTION; RISK FACTOR; STAPHYLOCOCCAL PNEUMONIA; THYROID CANCER; UREMIA; URETER TUMOR; URINARY TRACT OBSTRUCTION; ADOLESCENT; ADVERSE EFFECTS; COMPLICATION; DONOR; GRAFT REJECTION; INFECTION; KIDNEY FAILURE, CHRONIC; MORTALITY; NEOPLASM; PEDIATRICS; POSTOPERATIVE COMPLICATION; PROCEDURES; SEX DIFFERENCE; TREATMENT OUTCOME;

IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INFECTION; JAPAN; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; NEOPLASMS; PEDIATRICS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS; SEX FACTORS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 84904040637     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12299     Document Type: Article

References (44)

1. Hattori S, Yosioka K, Honda M, Ito H,; Japanese Society for Pediatric Nephrology. The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 2002: 17: 456-461.
2. Tejani A, Sullivan EK,. The impact of acute rejection on chronic rejection: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 2000: 4: 107-111.
3. Hodson EM, Knight JF, Sheil AG, et al. End-stage renal failure in children: 16 years' experience at one Australian centre. Med J Aust 1990: 152: 245-250.
4. Rizvi SA, Naqvi SA, Hussain Z, et al. Living-related pediatric renal transplants: A single-center experience from a developing country. Pediatr Transplant 2002: 6: 101-110.
5. Vats A, Gillingham K, Matas A, Chavers B,. Improved late graft survival and half-lives in pediatric kidney transplantation: A single center experience. Am J Transplant 2002: 2: 939-945.
6. Englund M, Berg U, Tydén G,. A longitudinal study of children who received renal transplants 10-20 years ago. Transplantation 2003: 76: 311-318.
7. Gulati S, Kumar A, Sharma RK, et al. Outcome of pediatric renal transplants in a developing country. Pediatr Nephrol 2004: 19: 96-100.
8. El-Husseini AA, Foda MA, Bakr MA, Shokeir AA, Sobh MA, Ghoneim MA,. Pediatric live-donor kidney transplantation in Mansoura Urology & Nephrology Center: A 28-year perspective. Pediatr Nephrol 2006: 21: 1464-1470.
9. Chacko B, Rajamanickam T, Neelakantan N, Tamilarasi V, John GT,. Pediatric renal transplantation-a single center experience of 15 yr from India. Pediatr Transplant 2007: 11: 844-849.
10. Gheith O, Sabry A, El-Baset SA, et al. Study of the effect of donor source on graft and patient survival in pediatric renal transplant recipients. Pediatr Nephrol 2008: 23: 2075-2079.
11. Vasudevan A, Iyengar A, Jose B, Phadke K,. Pediatric renal transplantation: A single-center experience. Transplant Proc 2008: 40: 1095-1098.
12. Wu ZX, Yang SL, Wu WZ, et al. The long-term outcomes of pediatric kidney transplantation: A single-center experience in China. Pediatr Transplant 2008: 12: 215-218.
13. Ng KH, Shrestha P, Aragon E, et al. Nineteen-year experience of paediatric renal transplantation in Singapore. Ann Acad Med Singapore 2009: 38: 300-309.
14. Majid A, Al Khalidi L, Ahmed BQ, Opelz G, Schaefer F,. Outcomes of kidney transplant tourism in children: A single center experience. Pediatr Nephrol 2010: 25: 155-159.
15. Abe T, Ichimaru N, Kakuta Y, et al. Long-term outcome of pediatric renal transplantation: A single center experience. Clin Transplant 2011: 25: 388-394.
16. Ethics Committee of the Transplantation Society. The consensus statement of the Amsterdam Forum on the Care of the Live Kidney Donor. Transplantation 2004: 78: 491-492.
17. Motoyama O, Hasegawa A, Aikawa A, et al. Final height in a prospective trial of late steroid withdrawal after pediatric renal transplantation treated with cyclosporine and mizoribine. Pediatr Transplant 2012: 16: 78-82.
18. Kinukawa T, Ono Y, Takeuchi N, Hattori R, Ohshima S,. Analysis of long-term results in kidney transplantation performed using a rejection-free protocol with cyclosporine and thoracic duct drainage. Transplant Proc 1997: 29: 946-947.
19. Schröeder R, Michelon T, Fagundes I, et al. Antigenemia for cytomegalovirus in renal transplantation: Choosing a cutoff for the diagnosis criteria in cytomegalovirus disease. Transplant Proc 2005: 37: 2781-2783.
20. Nankivell BJ, Kuypers DR,. Diagnosis and prevention of chronic kidney allograft loss. Lancet 2011: 378: 1428-1437.
21. Shishido S, Hyodo YY, Aoki Y, et al. Outcomes of pediatric ABO-incompatible kidney transplantations are equivalent to ABO-compatible controls. Transplant Proc 2012: 44: 214-216.
22. Vats AN, Donaldson L, Fine RN, Chavers BM,. Pretransplant dialysis status and outcome of renal transplantation in North American children: An NAPRTCS Study. North American Pediatric Renal Transplant Cooperative Study. Transplantation 2000: 69: 1414-1419.
23. Montgomery JR, Berger JC, Warren DS, James NT, Montgomery RA, Segev DL,. Outcomes of ABO-incompatible kidney transplantation in the United States. Transplantation 2012: 93: 603-609.
24. Lledõ-García E, Hernández-Fernández C, Subirá-Ríos D, et al. Cadaver donor kidney retransplantation in the pediatric patient: Complications and long-term outcome. J Urol 2011: 185 (Suppl. 6): 2582-2585.
25. Tangeraas T, Bjerre A, Lien B, et al. Long-term outcome of pediatric renal transplantation: The Norwegian experience in three eras 1970-2006. Pediatr Transplant 2008: 12: 762-768.
26. Sinha A, Hari P, Guleria S, et al. Outcome of pediatric renal transplantation in north India. Pediatr Transplant 2010: 14: 836-843.
27. Offner G, Latta K, Hoyer PF, et al. Kidney transplanted children come of age. Kidney Int 1999: 55: 1509-1517.
28. Bisigniano L, Lõpez-Rivera A, Tagliafichi V, Fernández V, Soratti C,. Factors associated with patient and graft survival using kidneys from cadaveric donors in transplant patients under 18 years of age in Argentina. Transplant Proc 2012: 44: 2235-2238.
29. Tan JC, Wadia PP, Coram M, et al. H-Y antibody development associates with acute rejection in female patients with male kidney transplants. Transplantation 2008: 86: 75-81.
30. Kim SJ, Gill JS,. H-Y incompatibility predicts short-term outcomes for kidney transplant recipients. J Am Soc Nephrol 2009: 20: 2025-2033.
31. Keith DS, Patrie JT,. H-Y antigen incompatibility not associated with adverse immunologic graft outcomes: Deceased donor pair analysis of the OPTN database. J Transplant 2011: 2011: 148457. doi: 10.1155/2011/148457.
32. Naesens M, Kambham N, Concepcion W, Salvatierra O Jr, Sarwal M,. The evolution of nonimmune histological injury and its clinical relevance in adult-sized kidney grafts in pediatric recipients. Am J Transplant 2007: 7: 2504-2514.
33. Berg UB, Bohlin AB, Tydén G,. Influence of donor and recipient ages and sex on graft function after pediatric renal transplantation. Transplantation 1997: 64: 1424-1428.
34. Neu AM, Stablein DM, Zachary A, Furth SL, Fivush BA,. Effect of parental donor sex on rejection in pediatric renal transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Transplant 1998: 2: 309-312.
35. Tejani A, Sullivan EK, Alexander S, Fine R, Harmon W, Lilienfeld D,. Posttransplant deaths and factors that influence the mortality rate in North American children. Transplantation 1994: 57: 547-553.
36. Koukourgianni F, Harambat J, Ranchin B, et al. Malignancy incidence after renal transplantation in children: A 20-year single-centre experience. Nephrol Dial Transplant 2010: 25: 611-616.
37. Berardinelli L, Raiteri M, Ghio L, Messa PG, Montagnino G,. The role of immunosuppression in malignancies among 351 pediatric renal transplant patients. Transplant Proc 2010: 42: 1166-1168.
38. Groothoff JW, Gruppen MP, Offringa M, et al. Mortality and causes of death of end-stage renal disease in children: A Dutch cohort study. Kidney Int 2002: 61: 621-629.
39. Mencarelli F, Marks SD,. Non-viral infections in children after renal transplantation. Pediatr Nephrol 2012: 27: 1465-1476.
40. Scornik JC, Bromberg JS, Norman DJ, Bhanderi M, Gitlin M, Petersen J,. An update on the impact of pre-transplant transfusions and allosensitization on time to renal transplant and on allograft survival. BMC Nephrol 2013: 14: 217.
41. McDonald SP, Craig JC,; Australian and New Zealand Paediatric Nephrology Association. Long-term survival of children with end-stage renal disease. N Engl J Med 2004: 350: 2654-2662.
42. Sampaio MS, Poommipanit N, Kuo HT, et al. Induction therapy in pediatric kidney transplant recipients discharged with a triple drug immunosuppressive regimen. Pediatr Transplant 2010: 14: 770-778.
43. Mitsnefes MM, Khoury PR, McEnery PT,. Early posttransplantation hypertension and poor long-term renal allograft survival in pediatric patients. J Pediatr 2003: 143: 98-103.
44. Baek CH, Yang WS, Park KS, Han DJ, Park JB, Park SK,. Infectious risks and optimal strength of maintenance immunosuppressants in rituximab-treated kidney transplantation. Nephron Extra 2012: 2: 66-75.